Repository logo
 
Publication

In Vitro Design of a Novel Lytic Bacteriophage Cocktail with Therapeutic Potential Against Organisms Causing Diabetic Foot Infections

dc.contributor.authorMendes, JJ
dc.contributor.authorLeandro, C
dc.contributor.authorMottola, C
dc.contributor.authorBarbosa, R
dc.contributor.authorSilva, F
dc.contributor.authorOliveira, M
dc.contributor.authorVilela, C
dc.contributor.authorMelo-Cristino, J
dc.contributor.authorGórski, A
dc.contributor.authorPimentel, M
dc.contributor.authorSão-José, C
dc.contributor.authorCavaco-Silva, P
dc.contributor.authorGarcia, M
dc.date.accessioned2017-10-24T14:33:28Z
dc.date.available2017-10-24T14:33:28Z
dc.date.issued2014-08
dc.description.abstractIn patients with diabetes mellitus, foot infections pose a significant risk. These are complex infections commonly caused by Staphylococcus aureus, Pseudomonas aeruginosa and Acinetobacter baumannii, all of which are potentially susceptible to bacteriophages. Here, we characterized five bacteriophages that we had determined previously to have antimicrobial and wound-healing potential in chronic S. aureus, P. aeruginosa and A. baumannii infections. Morphological and genetic features indicated that the bacteriophages were lytic members of the family Myoviridae or Podoviridae and did not harbour any known bacterial virulence genes. Combinations of the bacteriophages had broad host ranges for the different target bacterial species. The activity of the bacteriophages against planktonic cells revealed effective, early killing at 4 h, followed by bacterial regrowth to pre-treatment levels by 24 h. Using metabolic activity as a measure of cell viability within established biofilms, we found significant cell impairment following bacteriophage exposure. Repeated treatment every 4 h caused a further decrease in cell activity. The greatest effects on both planktonic and biofilm cells occurred at a bacteriophage : bacterium input multiplicity of 10. These studies on both planktonic cells and established biofilms allowed us to better evaluate the effects of a high input multiplicity and a multiple-dose treatment protocol, and the findings support further clinical development of bacteriophage therapy.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationJ Med Microbiol. 2014 Aug;63(Pt 8):1055-65pt_PT
dc.identifier.doi10.1099/jmm.0.071753-0pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/2769
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherMicrobiology Societypt_PT
dc.subjectAcinetobacter baumanniipt_PT
dc.subjectBacteriophagespt_PT
dc.subjectBiofilmspt_PT
dc.subjectDiabetic Footpt_PT
dc.subjectHumanspt_PT
dc.subjectPseudomonas aeruginosapt_PT
dc.subjectStaphylococcus aureuspt_PT
dc.subjectHSM MEDpt_PT
dc.titleIn Vitro Design of a Novel Lytic Bacteriophage Cocktail with Therapeutic Potential Against Organisms Causing Diabetic Foot Infectionspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1065pt_PT
oaire.citation.issuePt 8pt_PT
oaire.citation.startPage1055pt_PT
oaire.citation.titleJournal of Medical Microbiologypt_PT
oaire.citation.volume63pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
J Med Microb 2014 1055.pdf
Size:
557.17 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections